Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to DuoTrav from prior bimatoprost/timolol therapy in open-angle glaucoma or ocular hypertension
2011-000161-13Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jan 2012
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of travoprost and timolol in open-angle glaucoma (OAG) and ocular hypertension, sponsored by Alcon Inc. Primary endpoint: Change in intraocular pressure from baseline at final visit. Started Jan 2012; status: completed.
02
Drugs
travoprosttimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2011-000161-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000161-13.